Heterogeneities of attachment, chemotaxis, and protease production among clones with different metastatic potentials from a human pancreatic cancer cell line

The present study extends our investigations into the metastatic heterogeneity among four clonal cell lines (S2-007:H, S2-013:M1, S2-020:M2, and S2-028:L) from a human pancreatic cancer cell line (SUIT-2), and extends our discussion the positive correlation between metastatic potential and the type I collagenase activity of the cells, focusing on their interaction with extracellular matrix. Ability to attach to the reconstituted basement membrane (Matrigel) was higher for clone H than clone L during an observation period of 30–60 min, whereas clones M1 and M2 were found to be intermediate in ability. In densitometric and radioactive studies, clone L exhibited the lowest collagenolytic activity against mouse and human type IV collagen, while clone H exhibited the highest activity in the densitometric study and clone M1 was the highest in the radioactive study. The production of urinary-type plasminogen activator was highest in clone L and lowest in clone H. On the other hand, tissue-type plasminogen activator was highest in clone M2 and low in both clones H and L. Clone M2 exhibited the highest chemotactic activity toward diluted Matrigel, whereas clone L had the lowest activity. On the whole, these clones showed heterogenous interactions with an extracellular matrix. It is suggested that the attachment activity to basement membrane and the type IV collagenolytic activity of the cells may be positively correlated with their metastatic potential, whereas the production of urinary-type plasminogen activator was negatively correlated, but confirmation of these findings awaits further study.

[1]  A. Kojima,et al.  Correlation between CA19‐9 production in vitro and histological grades of differentiation in vivo in clones isolated from a human pancreatic cancer cell line (SUIT‐2) , 1992, Journal of gastroenterology and hepatology.

[2]  L. Liotta,et al.  Activation of human breast carcinoma collagenase through plasminogen activator. , 1980, Life sciences.

[3]  T. Iwamura,et al.  Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. , 1987, Japanese journal of cancer research : Gann.

[4]  I. Hart The selection and characterization of an invasive variant of the B16 melanoma. , 1979, The American journal of pathology.

[5]  L. Liotta,et al.  Role of laminin in the attachment and metastasis of murine tumor cells. , 1982, Cancer research.

[6]  H. Okazaki,et al.  High invasiveness associated with augmentation of motility in a fos-transferred highly metastatic rat 3Y1 cell line. , 1989, Cancer research.

[7]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.

[8]  L. Liotta,et al.  Partial purification and characterization of a neutral protease which cleaves type IV collagen. , 1981, Biochemistry.

[9]  A. Granelli‐Piperno,et al.  A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.

[10]  I. Ramshaw,et al.  Involvement of plasminogen activator production with tumor metastasis in a rat model. , 1984, Cancer research.

[11]  W. Stetler-Stevenson Type IV collagenases in tumor invasion and metastasis , 1990, Cancer and Metastasis Reviews.

[12]  I. Fidler,et al.  Thein vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants , 1989, Clinical & Experimental Metastasis.

[13]  C. Claudianos,et al.  Enhanced plasminogen activator production by highly metastatic variant cell lines of a rat mammary adenocarcinoma. , 1986, Invasion & metastasis.

[14]  U. Thorgeirsson,et al.  Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. , 1990, Cancer research.

[15]  L. Liotta,et al.  Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[16]  E. Ishikawa,et al.  Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder. , 1989, Cancer research.

[17]  R. Stephens,et al.  Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator , 1981, International journal of cancer.

[18]  D. Maslow Tabulation of results on the heterogeneity of cellular characteristics among cells from B16 mouse melanoma cell lines with different colonization potentials. A summary of sixty reports. , 1989, Invasion and Metastasis.

[19]  J. Richie,et al.  Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines. , 1980, Cancer research.

[20]  T. Iwamura,et al.  Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cancer cell line (SUIT-2) and sublines , 1992, Clinical & Experimental Metastasis.

[21]  G. Martin,et al.  Basement membrane and the invasive activity of metastatic tumor cells. , 1986, Journal of the National Cancer Institute.

[22]  L. Matrisian,et al.  Stromelysin in tumor progression and metastasis , 1990, Cancer and Metastasis Reviews.